Skip to main content
SpringerLink
Log in

Is there evidence for negative effects of antidepressants on suicidality in depressive patients?

A systematic review

  • REVIEW
  • Published:
European Archives of Psychiatry and Clinical Neuroscience Aims and scope Submit manuscript

Abstract

The role of antidepressants in suicide prevention is a major public health question given the high prevalence of both depression and depression-related suicidality. Therefore all available means should be utilised to clarify the influence of antidepressants on suicidality, especially in view of the ongoing intensive debate about possible suicidality-inducing effects of antidepressants that may outweigh their traditionally hypothesised beneficial effects. This paper gives a systematic and comprehensive review of the empirical data which might indicate that antidepressants have negative effects on suicidality. First, principal methodological issues related to this research question are discussed. Thereafter, the results of controlled trials and epidemiological and cohort studies are presented. Altogether, there seems to be only a small amount of evidence from different research approaches that antidepressants, not only serotonin reuptake inhibitors (SSRIs), might induce, aggravate or increase the risk of suicidal ideation and suicide attempts. As to suicide, there are no hints in this direction. TCAs have a higher risk of fatal outcome in overdose compared to SSRIs, which, in case of mono-intoxication, carry almost no risk of lethal consequences. The ongoing discussion about suicidality-inducing effects should not prevent physicians from prescribing SSRIs and other antidepressants to their patients if they are clinically indicated. However, they should take into account potential risks and manage them by good clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Nemeroff CB, Compton MT, Berger J (2001) The depressed suicidal patient. Assessment and treatment. Ann N Y Acad Sci 932:1–23

    Article  PubMed  CAS  Google Scholar 

  2. Möller HJ (2006) Evidence for beneficial effects of antidepressants on suicidality in depressive patients: A systematic review. Eur Arch Psychiatry Clinl Neurosci 256:329–343

    Google Scholar 

  3. Milane MS, Suchard MA, Wong ML, Licinio J (2006) Modeling of the temporal patterns of fluoxetine prescriptions and suicide rates in the United States. PLoS Med 3:e190

    PubMed  Google Scholar 

  4. Lapierre YD (2003) Suicidality with selective serotonin reuptake inhibitors: valid claim? J Psychiatry Neurosci 28:340–347

    PubMed  Google Scholar 

  5. Möller HJ (1992) Antidepressants—do they decrease or increase suicidality? Pharmacopsychiatry 25:249–253

    PubMed  Google Scholar 

  6. Baldwin D, Bullock T, Montgomery D, Montgomery S (1991) 5-HT reuptake inhibitors, tricyclic antidepressants and suicidal behaviour. Int Clin Psychopharmacol 6(Suppl 3):49–55

    PubMed  Google Scholar 

  7. Isacsson G (2000) Suicide prevention—a medical breakthrough? Acta Psychiatry Scand 102:113–117

    CAS  Google Scholar 

  8. Möller HJ (1992) Attempted suicide: efficacy of different aftercare strategies. Int Clin Psychopharmacol 6(Suppl 6):58–69

    PubMed  Google Scholar 

  9. Möller HJ (2003) Suicide, suicidality and suicide prevention in affective disorders. Acta Psychiatrica Scandinavica Supplementum:73–80

    Google Scholar 

  10. Walsh MT, Dinan TG (2001) Selective serotonin reuptake inhibitors and violence: a review of the available evidence. Acta Psychiatry Scand 104:84–91

    CAS  Google Scholar 

  11. Gunnell D, Middleton N, Whitley E, Dorling D, Frankel S (2003) Why are suicide rates rising in young men but falling in the elderly?—a time-series analysis of trends in England and Wales 1950–1998. Soc Sci Med 57:595–611

    PubMed  Google Scholar 

  12. Mines D, Hill D, Yu H, Novelli L (2005) Prevalence of risk factors for suicide in patients prescribed venlafaxine, fluoxetine, and citalopram. Pharmacoepidemiol Drug Saf 14:367–372

    PubMed  Google Scholar 

  13. Rujescu D, Thalmeier A, Möller HJ, Bronisch T, Giegling I (2006) Molecular genetic findings in suicidal behavior: What is beyond the serotonergic system? Arch Suicide Res (in press)

    Google Scholar 

  14. Tollefson GD, Rampey AH Jr, Beasley CM Jr, Enas GG, Potvin JH (1994) Absence of a relationship between adverse events and suicidality during pharmacotherapy for depression. J Clin Psychopharmacol 14:163–169

    PubMed  CAS  Google Scholar 

  15. Bauer MS, Wisniewski SR, Marangell LB, Chessick CA, Allen MH, Dennehy EB, Miklowitz DJ, Thase ME, Sachs GS (2006) Are antidepressants associated with new-onset suicidality in bipolar disorder? A prospective study of participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Clin Psychiatry 67:48–55

    Article  PubMed  CAS  Google Scholar 

  16. Conner KR, Hesselbrock VM, Schuckit MA, Hirsch JK, Knox KL, Meldrum S, Bucholz KK, Kramer J, Kuperman S, Preuss U, et al. (2006) Precontemplated and impulsive suicide attempts among individuals with alcohol dependence. J Stud Alcohol 67:95–101

    PubMed  Google Scholar 

  17. Fleischmann A, Bertolote JM, Belfer M, Beautrais A (2005) Completed suicide and psychiatric diagnoses in young people: a critical examination of the evidence. Am J Orthopsychiatry 75:676–683

    PubMed  Google Scholar 

  18. Harris EC, Barraclough B (1997) Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry 170:205–228

    PubMed  CAS  Google Scholar 

  19. Rihmer Z, Akiskal H (2006) Do antidepressants t(h)reat(en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries. J Affect Disord 94: 3–13

    PubMed  Google Scholar 

  20. Didham RC, McConnell DW, Blair HJ, Reith DM (2005) Suicide and self-harm following prescription of SSRIs and other antidepressants: confounding by indication. Br J Clin Pharmacol 60:519–525

    PubMed  Google Scholar 

  21. Grimes DA, Schulz KF (2002) Bias and causal associations in observational research. Lancet 359:248–252

    PubMed  Google Scholar 

  22. Warshaw MG, Keller MB (1996) The relationship between fluoxetine use and suicidal behavior in 654 subjects with anxiety disorders. J Clin Psychiatry 57:158–166

    PubMed  CAS  Google Scholar 

  23. Teicher MH, Glod C, Cole JO (1990) Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry 147:207–210

    PubMed  CAS  Google Scholar 

  24. Dasgupta K (1990) Additional case of suicidal ideation associated with fluoxetine. Am J Psychiatry 147:1570

    Google Scholar 

  25. Hoover CE (1990) Additional case of suicidal ideation associated with fluoxetine. Am J Psychiatry 147:1570–1571

    Google Scholar 

  26. Masand P, Gupta S, Dewan M (1991) Suicidal ideation related to fluoxetine treatment. N Engl J Med 324:420

    PubMed  CAS  Google Scholar 

  27. Rothschild AJ, Locke CA (1991) Reexposure to fluoxetine after serious suicide attempts by three patients: the role of akathisia. J Clin Psychiatry 52:491–493

    PubMed  CAS  Google Scholar 

  28. King RA, Riddle MA, Chappell PB, Hardin MT, Anderson GM, Lombroso P, Scahill L (1991) Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment. J Am Acad Child Adolesc Psychiat 30:179–186

    Article  CAS  Google Scholar 

  29. Vorstman J, Lahuis B, Buitelaar JK (2001) SSRIs associated with behavioral activation and suicidal ideation. J Am Acad Child Adolesc Psychiatry 40:1364–1365

    PubMed  CAS  Google Scholar 

  30. Healy D (2000) Emergence of antidepressant induced suicidality. Primary Care Psychiatry 6:23–28

    Google Scholar 

  31. Healy D, Langmaak C, Savage M (1999) Suicide in the course of the treatment of depression. J Psychopharmacol 13:94–99

    PubMed  CAS  Google Scholar 

  32. Möller HJ (2006) Pharmacological/clinical mechanisms by which antidepressants could theoretically induce suicidal ideations or behaviour. In preparation

  33. Miller RA (1990) Discussion of fluoxetine and suicidal tendencies. Am J Psychiatry 147:1571–1572

    Google Scholar 

  34. Tollefson GD (1990) Fluoxetine and suicidal ideation. Am J Psychiatry 147:1691–1693

    PubMed  CAS  Google Scholar 

  35. Teicher MH, Glod CA, Cole JO (1991) Fluoxetine and preoccupation with suicide – Dr Teicher and associates reply. Am J Psychiatry 148:1260–1262

    Google Scholar 

  36. Beasley CM Jr, Dornseif BE, Bosomworth JC, Sayler ME, Rampey AH Jr, Heiligenstein JH, Thompson VL, Murphy DJ, Masica DN (1991) Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. Br Med J 303:685–692

    Google Scholar 

  37. Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278–296

    PubMed  CAS  Google Scholar 

  38. Montgomery SA, Dunner DL, Dunbar GC (1995) Reduction of suicidal thoughts with paroxetine in comparison with reference antidepressants and placebo. Eur Neuropsychopharmacol 5:5–13

    PubMed  CAS  Google Scholar 

  39. Aursnes I, Tvete IF, Gaasemyr J, Natvig B (2005) Suicide attempts in clinical trials with paroxetine randomised against placebo. BMC Med 3:14

    PubMed  Google Scholar 

  40. Glaxo Smith Kline (2006) Paroxetine: Important safety information regarding the risk of suicidal behaviour. Letter to Healthcare Professionals (Europe). http://www.gsk.com/media/par_current_analysis

  41. Pedersen AG (2005) Escitalopram and suicidality in adult depression and anxiety. Int Clin Psychopharmacol 20:139–143

    PubMed  Google Scholar 

  42. Healy D, Whitaker C (2003) Antidepressants and suicide: risk-benefit conundrums. J Psychiatry Neurosci 28:331–337

    PubMed  Google Scholar 

  43. Khan A, Warner HA, Brown WA (2000) Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database. Arch Gen Psychiatry 57:311–317

    PubMed  CAS  Google Scholar 

  44. Khan A, Khan S, Kolts R, Brown WA (2003) Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports. Am J Psychiatry 160:790–792

    PubMed  Google Scholar 

  45. Brecher M (1991) FDA review and evaluation of clinical data original NDA 20–021, Paroxetine Safety Review June 19th

  46. Lee H (1991) Statistical reviews on Sertraline for FDA, August 14th 1990 and January 31st 1991

  47. Khan A, Khan SR, Leventhal RM, Brown WA (2001) Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: a replication analysis of the Food and Drug Administration Database. Int J Neuropsychopharmacol 4:113–118

    PubMed  CAS  Google Scholar 

  48. Kirsch I, Moore TJ, Scoboria A, Nicholls SS (2002) The emperor’s new drugs: an analysis of antidepressant medication data submitted to the US Food and Drug Administration. Prevention and Treatment. Article 23. Posted 15 Jul 2002. http://www.journals.apa.org/prevention/volume5/pre0050023a

  49. Storosum JG, van Zwieten BJ, van den BW, Gersons BP, Broekmans AW (2001) Suicide risk in placebo-controlled studies of major depression. Am J Psychiat 158:1271–1275

    PubMed  CAS  Google Scholar 

  50. Rouillon F (1994) Long-term care with antidepressants. Encephale 20:291–293

    PubMed  Google Scholar 

  51. Rouillon F, Lejoyeux M, Filteau MJ (1992) Unwanted effects of long-term treatment. In: Rouillon F, Montgomery S (eds) Long-term treatment of depression. Perspectives in psychiatry. Chichester, John Wiley, pp 81–111

    Google Scholar 

  52. Gunnell D, Saperia J, Ashby D (2005) Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA’s safety review. Brit Med J 330:385

    PubMed  CAS  Google Scholar 

  53. Fergusson D, Doucette S, Glass KC, Shapiro S, Healy D, Hebert P, Hutton B (2005) Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. Br Med J 330:396

    CAS  Google Scholar 

  54. Fergusson D, Doucette S, Glass KC, Shapiro S, Healy D, Hebert P, Hutton B (2005) Correction and clarification. BMJ 330:653

    Google Scholar 

  55. Holtmann M, Bolte S, Poustka F (2005) Suicidality in depressive children and adolescents during treatment with selective serotonin reuptake inhibitors Review and meta-analysis of the available randomised, placebo controlled trials. Nervenarzt Epub ahead of print

  56. Carlsten A, Waern M, Ekedahl A, Ranstam J (2001) Antidepressant medication and suicide in Sweden. Pharmacoepidemiol Drug Saf 10:525–530

    PubMed  CAS  Google Scholar 

  57. Gibbons RD, Hur K, Bhaumik DK, Mann JJ (2005) The relationship between antidepressant medication use and rate of suicide. Arch Gen Psychiatry 62:165–172

    PubMed  CAS  Google Scholar 

  58. Grunebaum MF, Ellis SP, Li S, Oquendo MA, Mann JJ (2004) Antidepressants and suicide risk in the United States, 1985–1999. J Clin Psychiatry 65:1456–1462

    Article  PubMed  Google Scholar 

  59. Hall WD, Mant A, Mitchell PB, Rendle VA, Hickie IB, McManus P (2003) Association between antidepressant prescribing and suicide in Australia, 1991–2000: trend analysis. Brit Med J 326:1008

    PubMed  Google Scholar 

  60. Kelly CB, Ansari T, Rafferty T, Stevenson M (2003) Antidepressant prescribing and suicide rate in Northern Ireland. Eur Psychiatry 18:325–328

    PubMed  Google Scholar 

  61. Rihmer Z (2001) Can better recognition and treatment of depression reduce suicide rates? A brief review. Eur Psychiatry 16:406–409

    PubMed  CAS  Google Scholar 

  62. Fava M, Rosenbaum JF (1991) Suicidality and fluoxetine: is there a relationship? J Clin Psychiatry 52:108–111

    PubMed  CAS  Google Scholar 

  63. Jick SS, Dean AD, Jick H (1995) Antidepressants and suicide. BMJ 310:215–218

    PubMed  CAS  Google Scholar 

  64. Jick H, Kaye JA, Jick SS (2004) Antidepressants and the risk of suicidal behaviors. JAMA 292:338–343

    PubMed  CAS  Google Scholar 

  65. Martinez C, Rietbrock S, Wise L, Ashby D, Chick J, Moseley J, Evans S, Gunnell D (2005) Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study. BMJ 330:389

    PubMed  CAS  Google Scholar 

  66. Leon AC, Keller MB, Warshaw MG, Mueller TI, Solomon DA, Coryell W, Endicott J (1999) Prospective study of fluoxetine treatment and suicidal behavior in affectively ill subjects. Am J Psychiatry 156:195–201

    PubMed  CAS  Google Scholar 

  67. Donovan S, Kelleher MJ, Lambourn J, Foster R (1999) The occurrence of suicide following the prescription of antidepressant drugs. Arch Suicide Res 5:181–192

    Google Scholar 

  68. Donovan S, Clayton A, Beeharry M, Jones S, Kirk C, Waters K, Gardner D, Faulding J, Madeley R (2000) Deliberate self-harm and antidepressant drugs. Investigation of a possible link. Br J Psychiatry 177:551–556

    PubMed  CAS  Google Scholar 

  69. Henry JA, Alexander CA, Sener EK (1995) Relative mortality from overdose of antidepressants. BMJ 310:221–224

    PubMed  CAS  Google Scholar 

  70. Simon GE, Savarino J, Operskalski B, Wang PS (2006) Suicide risk during antidepressant treatment. Am J Psychiatry 163:41–47

    PubMed  Google Scholar 

  71. Mackay FJ, Dunn NR, Wilton LV, Pearce GL, Freemantle SN, Mann RD (1997) A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies. Pharmacoepidemiol Drug Saf 6:235–246

    PubMed  CAS  Google Scholar 

  72. Tiihonen J, et al. (2006) Presentation S.13.03, 19th ECNP Congress, Paris, September 2006

  73. Kerr GW, McGuffie AC, Wilkie S (2001) Tricyclic antidepressant overdose: a review. Emerg Med J 18:236–241

    PubMed  CAS  Google Scholar 

  74. Whyte IM, Dawson AH, Buckley NA (2003) Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. QJM 96:369–374

    PubMed  CAS  Google Scholar 

  75. Gunnell D, Ho D, Murray V (2004) Medical management of deliberate drug overdose: a neglected area for suicide prevention? Emerg Med J 21:35–38

    PubMed  CAS  Google Scholar 

  76. Freemantle N, House A, Song F, Mason JM, Sheldon TA (1994) Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicide. BMJ 309:249–253

    PubMed  CAS  Google Scholar 

  77. Cassidy S, Henry J (1987) Fatal toxicity of antidepressant drugs in overdose. Br Med J (Clin Res Ed) 295:1021–1024

    Article  CAS  Google Scholar 

  78. Farmer RD, Pinder RM (1989) Why do fatal overdose rates vary between antidepressants? Acta Psychiatr Scand Suppl 354:25–35

    PubMed  CAS  Google Scholar 

  79. Henry JA (1989) A fatal toxicity index for antidepressant poisoning. Acta Psychiatr Scand Suppl 354:37–45

    PubMed  CAS  Google Scholar 

  80. Ohberg A, Lonnqvist J, Sarna S, Vuori E, Penttila A (1995) Trends and availability of suicide methods in Finland. Proposals for restrictive measures. Br J Psychiatry 166:35–43

    PubMed  CAS  Google Scholar 

  81. Henry JA (1997) Epidemiology and relative toxicity of antidepressant drugs in overdose. Drug Saf 16:374–390

    PubMed  CAS  Google Scholar 

  82. Frey R, Schreinzer D, Stimpfl T, Vycudilik W, Berzlanovich A, Kasper S (2000) Suicide by antidepressant intoxication identified at autopsy in Vienna from 1991–1997: the favourable consequences of the increasing use of SSRIs. Eur Neuropsychopharmacol 10:133–142

    PubMed  CAS  Google Scholar 

  83. Shah R, Uren Z, Baker A, Majeed A (2001) Deaths from antidepressants in England and Wales 1993–1997: analysis of a new national database. Psychol Med 31:1203–1210

    PubMed  CAS  Google Scholar 

  84. Frey R, Schreinzer D, Stimpfl T, Vycudilik W, Berzlanovich A, Kasper S (2002) Fatal poisonings with antidepressive drugs and neuroleptics. Analysis of a correlation with prescriptions in Vienna 1991 to 1997. Nervenarzt 73:629–636

    PubMed  CAS  Google Scholar 

  85. Cheeta S, Schifano F, Oyefeso A, Webb L, Ghodse AH (2004) Antidepressant-related deaths and antidepressant prescriptions in England and Wales, 1998–2000. Br J Psychiatry 184:41–47

    PubMed  Google Scholar 

  86. Ghodse H, Oyefeso A, Webb L, Pollard M, Shifano F, Corkery J (2002) Drug-related deaths as reported by coroners in England and Wales, January-June 2001 (np-SAD Surveillance Report no. 8). St George’s Hospital Medical School, London

    Google Scholar 

  87. Kapur S, Mieczkowski T, Mann JJ (1992) Antidepressant medications and the relative risk of suicide attempt and suicide. JAMA 268:3441–3445

    PubMed  CAS  Google Scholar 

  88. Isacsson G, Holmgren P, Ahlner J (2005) Selective serotonin reuptake inhibitor antidepressants and the risk of suicide: a controlled forensic database study of 14,857 suicides. Acta Psychiatr Scand 111:286–290

    PubMed  CAS  Google Scholar 

  89. Bateman DN, Chick J, Good AM, Kelly CA, Masterton G (2004) Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose? Eur J Clin Pharmacol 60:221–224

    PubMed  CAS  Google Scholar 

  90. Möller HJ (2004) SSRIs: are the accusations justified? World J Biol Psychiatry 5:174–175

    PubMed  Google Scholar 

  91. Andrade C, Bhakta SG, Singh NM (2006) Controversy revisited: Selective serotonin reuptake inhibitors in pediatric depression. World J Biol Psychiatry 7:251–260

    Google Scholar 

  92. Hjalmarsson L, Corcos M, Jeammet P (2005) Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks). Encephale 31:309–316

    Article  PubMed  CAS  Google Scholar 

  93. Scahill L, Hamrin V, Pachler ME (2005) The use of selective serotonin reuptake inhibitors in children and adolescents with major depression. J Child Adolesc Psychiatr Nurs 18:86–89

    PubMed  Google Scholar 

  94. Wohlfarth TD, van Zwieten BJ, Lekkerkerker FJ, Gispen-de Wied CC, Ruis JR, Elferink AJ, Storosum JG (2006) Antidepressants use in children and adolescents and the risk of suicide. Eur Neuropsychopharmacol 16:79–83

    PubMed  CAS  Google Scholar 

  95. Wong IC, Besag FM, Santosh PJ, Murray ML (2004) Use of selective serotonin reuptake inhibitors in children and adolescents. Drug Saf 27:991–1000

    PubMed  CAS  Google Scholar 

  96. Vitiello B, Swedo S (2004) Antidepressant medications in children. N Engl J Med 350:1489–1491

    PubMed  CAS  Google Scholar 

  97. Gunnell D, Ashby D (2004) Antidepressants and suicide: what is the balance of benefit and harm. BMJ 329:34–38

    PubMed  CAS  Google Scholar 

  98. Nutt DJ (2003) Death and dependence: current controversies over the selective serotonin reuptake inhibitors. J Psychopharmacol 17:355–364

    PubMed  CAS  Google Scholar 

  99. Mackay FR, Dunn NR, Martin RM, Pearce GL, Freemantle SN, Mann RD (1999) Newer antidepressants: a comparison of tolerability in general practice. Br J Gen Pract 49:892–896

    PubMed  CAS  Google Scholar 

  100. McClure GM (2001) Suicide in children and adolescents in England and Wales 1970–1998. Br J Psychiatry 178:469–474

    PubMed  CAS  Google Scholar 

  101. Hawton K, Hall S, Simkin S, Bale L, Bond A, Codd S, Stewart A (2003) Deliberate self-harm in adolescents: a study of characteristics and trends in Oxford, 1990–2000. J Child Psychol Psychiatry 44:1191–1198

    PubMed  Google Scholar 

  102. Olfson M, Shaffer D, Marcus SC, Greenberg T (2003) Relationship between antidepressant medication treatment and suicide in adolescents. Arch Gen Psychiatry 60:978–982

    PubMed  Google Scholar 

  103. Harris EC, Barraclough B (1998) Excess mortality of mental disorder. Br J Psychiatry 173:11–53

    Article  PubMed  CAS  Google Scholar 

  104. FDA Public Health Advisory (2004) Suicidality in children and adolescents being treated with antidepressant medications. http://www.fda.gov/cder/drug/antidepressants/SSRIPHA200410

  105. Emea (2005) European Medicines Agency finalises review of antidepressants in children and adolescents. http://www.emea.eu.int/pdfs/human/press/pr/12891805en

  106. Hammad TA, Laughren T, Racoosin J (2006) Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 63:332–339

    PubMed  CAS  Google Scholar 

  107. Mann JJ, Emslie G, Baldessarini RJ, Beardslee W, Fawcett JA, Goodwin FK, Leon AC, Meltzer HY, Ryan ND, Shaffer D et al (2006) ACNP Task Force report on SSRIs and suicidal behavior in youth. Neuropsychopharmacol 31:473–492

    CAS  Google Scholar 

  108. Jureidini JN, Doecke CJ, Mansfield PR, Haby MM, Menkes DB, Tonkin AL (2004) Efficacy and safety of antidepressants for children and adolescents. BMJ 328:879–883

    PubMed  CAS  Google Scholar 

  109. Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E (2004) Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 363:1341–1345

    PubMed  CAS  Google Scholar 

  110. Geller DA, Biederman J, Stewart SE, Mullin B, Martin A, Spencer T, Faraone SV (2003) Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. Am J Psychiatry 160:1919–1928

    PubMed  Google Scholar 

  111. Nutt DJ (2005) Death by tricyclic: the real antidepressant scandal? J Psychopharmacol 19:123–124

    PubMed  Google Scholar 

  112. Brent DA (2004) Antidepressants and pediatric depression—the risk of doing nothing. N Engl J Med 351:1598–1601

    PubMed  CAS  Google Scholar 

  113. Balazs J, Benazzi F, Rihmer Z, Rihmer A, Akiskal KK, Akiskal HS (2006) The close link between suicide attempts and mixed (bipolar) depression: implications for suicide prevention. J Affect Disord 91:133–138

    PubMed  Google Scholar 

  114. Teicher MH, Glod CA, Cole JO (1993) Antidepressant drugs and the emergence of suicidal tendencies. Drug Safety 8:186–212

    PubMed  CAS  Google Scholar 

  115. Geddes JR, Carney SM, Davies C, Furukawa TA, Kupfer DJ, Frank E, Goodwin GM (2003) Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 361:653–661

    PubMed  CAS  Google Scholar 

  116. Reynolds CF III, Dew MA, Pollock BG, Mulsant BH, Frank E, Miller MD, Houck PR, Mazumdar S, Butters MA, Stack JA, et al. (2006) Maintenance treatment of major depression in old age. N Engl J Med 354:1130–1138

    PubMed  CAS  Google Scholar 

  117. Volz HP, Baghai TC, Möller HJ (2006) Drug treatment of depression in the 2000s—an overview of achievements in the last ten years and future possibilities. World J Biol Psychiatry 7:198–222

    PubMed  Google Scholar 

  118. Moncrieff J, Kirsch I (2005) Efficacy of antidepressants in adults. BMJ 331:155–157

    PubMed  Google Scholar 

  119. Geddes JR, Cipriani A (2004) Selective serotonin reuptake inhibitors. BMJ 329:809–810

    PubMed  Google Scholar 

  120. Vaiva G, Vaiva G, Ducrocq F, Meyer P, Mathieu D, Philippe A, Libersa C, Goudemand M (2006) Effect of telephone contact on further suicide attempts in patients discharged from an emergency department: randomised controlled study. BMJ 332:1241–1245

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Ludwig-Maximilians-University, Nussbaumstrasse 7, 80336, Munich, Germany

    Hans-Jürgen Möller

Authors
  1. Hans-Jürgen Möller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hans-Jürgen Möller.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Möller, HJ. Is there evidence for negative effects of antidepressants on suicidality in depressive patients?. Eur Arch Psychiatry Clin Neurosci 256, 476–496 (2006). https://doi.org/10.1007/s00406-006-0689-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00406-006-0689-8

Keywords

Search

Navigation